ask="N/A"
ask_size="N/A"
average_daily_volume="185815"
bid="12.15"
bid_size="100"
book_value="6.18"
change="+0.05"
change_from_200_day_moving_average="0.77"
change_from_50_day_moving_average="-1.81"
change_from_52_week_high="-5.75"
change_From_52_week_low="6.20"
change_in_percent="+0.27%"
close="18.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.18"
ebitda="-77.71M"
eps_estimate_current_year="-3.60"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-3.40"
ex_dividend_date="N/A"
float_shares="19254000"
high="18.92"
high_52_weeks="24.30"
last_trade_date="3/8/2017"
last_trade_price="18.55"
last_trade_size="6760"
last_trade_time="4:00pm"
low="18.40"
low_52_weeks="12.35"
market_capitalization="543.87M"
moving_average_200_day="17.78"
moving_average_50_day="20.36"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="39.67"
open="18.40"
pe_ratio="N/A"
peg_ratio="-0.44"
percent_change_from_200_day_moving_average="+4.31%"
percent_change_from_50_day_moving_average="-8.89%"
percent_change_from_52_week_high="-23.66%"
percent_change_from_52_week_low="+50.20%"
previous_close="18.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.99"
price_per_sales="1808.00"
revenue="300000.00"
shares_outstanding="29319000"
short_ratio="32.21"
stock_exchange="NGM"
symbol="RVNC"
volume="129691"
weeks_range_52="12.35 - 24.30"
